Cases
Search
Statistics
Estimate
SEARCH
Show Filters
Decision Date
2020
(1)
2018
(1)
2017
(1)
2008
(3)
2007
(1)
Decision
Transfer
(8)
Complainant
Sanofi
(3)
Sanofi-aventis
(2)
Sanofi-Aventis
(2)
SANOFI-AVENTIS
(1)
Merrell Pharmaceuticals Inc.
(1)
Aventis Inc.
(1)
Respondent
Yellow Fish Designs
(1)
Vertical Markets Online
(1)
Private Registration / Domain Admin
(1)
Moniker Privacy Services / Unifund Corporation
(1)
Michael Robert
(1)
Howard Hoffman
(1)
Davie Kearney
(1)
Panelist
Richard Tan
(1)
Philip N. Argy
(1)
Matthew S. Harris
(1)
Luca Barbero
(1)
Jon Lang
(1)
Francisco Castillo-Chacón
(1)
Dilek Ustun Ekdial
(1)
Daniel J. Gervais
(1)
Complainant Country
France
(8)
Complainant Representative
Selarl Marchais De Candé
(3)
Bird & Bird LLP
(3)
Marchais
(2)
Respondent Country
United States
(8)
Respondent Reply
Yes
(3)
No
(5)
RDNH Status
No
(8)
Case Language
English
(8)
Case Particular
D
(8)
Number Of Domains
1
(5)
2
(2)
4
(1)
Domain Extension
com
(5)
net
(2)
org
(1)
biz
(1)
Domain Extension Type
gTLD
(8)
Domain Length
7
(1)
8
(8)
9
(2)
15
(1)
Includes Hyphen
Yes
(1)
No
(7)
Includes Number
No
(8)
Includes Letter
Yes
(8)
Domain Registrar
GoDaddy.com, LLC
(3)
eNom, Inc.
(1)
TurnCommerce, Inc. DBA NameBright.com
(1)
OnlineNIC, Inc.
(1)
Moniker Online Services LLC
(1)
1API GmbH
(1)
8
cases found.
Complainant Country: France
Complainant: Sanofi
Domain Length: 8
Respondent Country: United States
Reset Search
sanofica.com
Transfer
WIPO D2020-2610
(Decision Date: Nov. 23, 2020)
sanofitv.com
Transfer
WIPO D2018-2327
(Decision Date: Dec. 3, 2018)
warmuapp.com
Transfer
WIPO D2017-0028
(Decision Date: March 1, 2017)
allegrad.net, wwwambien.org
Transfer
WIPO D2008-1601
(Decision Date: Dec. 26, 2008)
ambienrx.net
Transfer
WIPO D2007-1767
(Decision Date: Jan. 23, 2008)
eloxatin.biz
Transfer
WIPO D2007-1758
(Decision Date: Jan. 30, 2008)
allegrra.com, ambienn.com, ammbien.com and wwwplavix.com
Transfer
WIPO D2007-0042
(Decision Date: March 16, 2007)
ambien-i.com, buy-ambien-here.com
Transfer
WIPO D2006-0861
Stay updated! Get new cases and decisions by daily email.
leave this field blank to prove your humanity
Subscribe
Scroll